Chemotherapy dose threshold below which male childhood cancer survivors are likely to have normal sperm production has been discovered by St. Jude Children's Research Hospital investigators. The study appears in September 17 edition of the journal iLancet Oncology/i. The study involved drugs called alkylating agents that are widely used to treat a variety of pediatric cancers. Unlike other chemotherapy, alkylating agents are known to damage sperm production. ...
Read MoreYou have just read an article categorized health
titled Improved Risk Identification Will Aid Fertility Preservation in Young Male Cancer Patients: Study.
Written by:
editor - Saturday, November 1, 2014
There are currently no comments for "Improved Risk Identification Will Aid Fertility Preservation in Young Male Cancer Patients: Study"
Post a Comment